Results 21 to 30 of about 2,013 (145)

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification [PDF]

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Karoline Gleixner, , Nadja Jakel
exaly   +2 more sources

Remission of indolent systemic mastocytosis in the absence of targeted therapy. [PDF]

J Allergy Clin Immunol Pract, 2022
Constantine GM, Metcalfe DD, Akin C, Sun X, Bai Y, Eisch AR, Maric I, Komarow HD.   +7 more
europepmc   +3 more sources

Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms [PDF]

Frontiers in Allergy
Tracy I George, Andrew T Kuykendall, Matthew Hamilton   +2 more
exaly   +2 more sources

Primary cicatricial alopecia associated with systemic indolent mastocytosis [PDF]

JAAD Case Reports, 2020
We present a case of a 63-year-old woman diagnosed with indolent cutaneous and systemic mastocytosis (SM) who presented with hair loss due to primary cicatricial alopecia (PCA).
Sonya Prasad, BA, Brianna De Souza, MD, Laura J. Burns, BS, Maryanne M. Senna, MD   +3 more
doaj   +3 more sources

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]

Cureus
Indolent systemic mastocytosis (ISM) is a clonal mast cell disorder characterized by recurrent symptoms that can persist despite treatment with antihistamines, leukotriene antagonists, and mast cell stabilizers. Treatment options are limited when symptoms remain refractory, and avapritinib is contraindicated or declined.
Minbaeva S, Tyring SK.
europepmc   +3 more sources

An intriguing coexistence of cutaneous and systemic mastocytosis with atypical chronic myeloid leukemia: An associated hematologic neoplasm (SM-AHN)

Journal of Applied Hematology, 2021
Systemic mastocytosis (SM) characterized by focal or diffuse infiltrates of neoplastic mast cells can range from indolent cutaneous disease to aggressive systemic disease.
B R Rajalakshmi, Vijaya Basavaraj
doaj   +1 more source

Indolent systemic mastocytosis mimicking Crohn's disease. [PDF]

Ann Gastroenterol, 2019
Mastocytosis is a rare and heterogeneous group of diseases whose common element is the presence of dense mast-cell infiltrates in various tissues. The gastrointestinal (GI) tract is frequently affected with vague and subtle manifestations, making the diagnosis of GI mastocytosis rather formidable and challenging. The diagnosis of the disease requires a
Hadjivasilis A, Ioakim KJ, Neocleous A, Demetriou K, Panjiyar S, Iacovou F, Michaelides D, Potamitis G.   +7 more
europepmc   +4 more sources

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study [PDF]

Lancet, The, 2017
Cristina Bulai Livideanu, Sylvie Fraitag, Olivier Lortholary   +2 more
exaly   +2 more sources

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Haematologica, 2020
A high allele burden of the KIT D816V mutation in peripheral blood or bone marrow aspirates indicates multi-lineage hematopoietic involvement and has been associated with an aggressive clinical course of systemic mastocytosis.
Georg Greiner, Michael Gurbisz, Franz Ratzinger, Nadine Witzeneder, Svenja Verena Class, Gregor Eisenwort, Ingrid Simonitsch-Klupp, Harald Esterbauer, Matthias Mayerhofer, Leonhard Müllauer, Wolfgang R. Sperr, Peter Valent, Gregor Hoermann   +12 more
doaj   +1 more source

Comprehensive mastocytosis data analysis from a single center

BMC Cancer, 2023
Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma or localized mast cell (MC) tumors.
Tarık Onur Tiryaki, Sıdıka Gülkan Özkan, Simge Erdem, Aynur Dağlar Aday, İpek Yönal Hindilerden, Aslı Gelincik, Can Baykal, Gülçin Yegen, İbrahim Öner Doğan, Nesimi Büyükbabani, Meliha Nalçacı, Akif Selim Yavuz   +11 more
doaj   +1 more source